Bloomberg News

Is Insulin a Hotter Product Than Apple's IPad?

April 27, 2012

Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about first-quarter profit. Matthew Weston, a pharmaceutical analyst at Credit Suisse, says "arguably the global diabetes epidemic offers better growth potential versus tech innovation." (Source: Bloomberg)

Running Time: 05:30


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus